The Histopathology and Biochemistry of Phenobarbitone-Induced Liver Nodules in C3H Mice

  • S. D. Gangolli
  • B. G. Lake
  • J. G. Evans
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 10)


The sequential development of hepatic nodules induced by phenobarbitone (PB) has been studied in the C3H/He strain of mouse, a strain prone to the development of spontaneous liver tumours. PB was administered in the diet to young male animals at a dose level of 85 mg/kg/day for up to 91 weeks. Control and PB-treated mice developed hepatic nodules within 60 weeks. In control animals the nodules consisted of small basophilic cells, and by 80 weeks a small proportion of the animals had developed unequivocal hepatocellular carcinoma. The basophilic nodules were similar in many respects to those induced by N-nitrosodiethylamine. In PB-treated mice the incidence of basophilic nodules was similar to that in controls. These animals also developed hepatic nodules formed of large eosinophilic cells which were readily dissectable from the surrounding host tissue by 60 weeks.

Biochemical investigations into the large eosinophilic nodules from PB treated mice showed that both Phase I and Phase II types of xenobiotic metabolizing enzyme activities were induced to levels either similar to, or greater than in the surrounding host tissue. In contrast, enzyme activities in basophilic nodules from untreated mice killed at 91 weeks, were generally similar to or lower than in the surrounding host tissue.

The presence of eosinophilic nodules did not lead to an increase in the incidence of hepatocellular carcinoma in the PB-treated C3H/He mice. Concurrent experiments conducted in the C57BL/6 strain of mouse did not result in the development of liver nodules at 60 weeks. Thus, the eosinophilic nodules induced by phenobarbitone in C3H/He mice appear to be distinctly different from the basophilic liver nodules arising spontaneously or to basophilic nodules produced by the hepatocellular carcinogen N-nitrosodiethylamine.

Key words

Phenobarbitone Nitrosodiethylamine Mouse C3H Strain C57 Strain Liver tumours 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Altman FP (1972) Quantitative dehydrogenase histochemistry with special reference to pentose-shunt dehydrogenase. Prog in Histochemie Cytochem Fischer Stuttgart 4: 225–273Google Scholar
  2. Becker FF (1982) Morphological classification of mouse liver tumors based on biological characteristics. Cancer Res 42: 3918–3923PubMedGoogle Scholar
  3. Butler WH (1978) Long-term effects of phenobarbitone-Na on male Fischer rats. Br J Cancer 37:418– 423PubMedCrossRefGoogle Scholar
  4. Chayen J, Bitensky L, Butcher RG (1973) In: Practical Histochemistry. John Wiley and Sons, London New York, pp 122–127 )Google Scholar
  5. Collins MA, Lake BG, Evans JG, Walker R, Gangolli SD, Conning DM (1984) Sustained induction of hepatic xenobiotic metabolising enzyme activities by phenobarbitone in C3H/He mice: relevance to nodule formation. Toxicology 33: 129–144PubMedCrossRefGoogle Scholar
  6. Engelese LD, Hollander CF, Misdorp W (1974) A sex-dependent difference in the type of tumors induced by dimethylnitrosamine in the livers of C3Hf mice. Eur J Cancer 10: 129–135Google Scholar
  7. Frith CH, Ward JM (1980) A morphological classification of proliferative and neoplastic hepatic lesions in mice. J Environ Pathol Toxicol 3: 329–351Google Scholar
  8. Gellatly JBM (1974) The natural history of hepatic parenchymal nodule formation in a colony of C57BL mice with reference to the effect of diet. In: Butler WH, Newberne PM (ed) Mouse hepatic neoplasia. Elsevier Press Inc, Amsterdam, pp 77–109Google Scholar
  9. Hoover KL, Ward JM, Stinson SF (1980) Histopathologic differences between liver tumors in untreated (C57BL/6 x C3H) F i (B6C3FX) mice and nitrofen-fed mice. J Natl Cancer Inst 65:937– 948PubMedGoogle Scholar
  10. Jalanko H, Ruoslahti E (1979) Differential expression of a-fetoprotein and y-glutamyltranspeptidase in chemical and spontaneous hepatocarcinogenesis. Cancer Res 39: 3495–3501PubMedGoogle Scholar
  11. Lake BG, Foster JR, Collins MA, Stubberfield CR, Gangolli SD, Srivastava SP (1982) Studies on the effects of orally administered dicyclohexyl phthalate in the rat. Acta Pharmacol Toxicol 51: 217–226CrossRefGoogle Scholar
  12. Ohmori T, Rice JM, Williams GM (1981) Histochemical characteristics of spontaneous and chemically induced hepatocellular neoplasms in mice and the development of neoplasms with y-glutamyl transpeptidase activity during phenobarbital exposure. Histochem J 13: 85–99PubMedCrossRefGoogle Scholar
  13. Peraino C, Fry RJM, Staffeldt E (1973) Enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary phenobarbital. J Natl Cancer Inst 51: 1349–1350PubMedGoogle Scholar
  14. Ponomarkov V, Tomatis L (1976) The effect of long-term administration of phenobarbitone in CF-1 mice. Cancer Lett 1: 165–172CrossRefGoogle Scholar
  15. Rossi L, Ravera M, Repetti G, Santi L (1977) Long-term administration of DDT or phenobarbital-Na in Wistar rats. Int J Cancer 19: 179–185PubMedCrossRefGoogle Scholar
  16. Rutenburg AM, Kim H, Fischbein JW, Hanker JS, Wasserkrug HL, Seligman AM (1969) Histochemical and ultrastructural demonstration of y-glutamyl transpeptidase activity. J Histochem Cytochem 17: 517–526PubMedCrossRefGoogle Scholar
  17. Schulte-Hermann R (1979) Reactions of the liver to injury: Adaption. In: Farber E, Fisher MM (ed) Toxic Liver Injury, part A. Marcel-Dekker Inc, New York, pp 385–445Google Scholar
  18. Tennekes HA, Elder L, Kunz HW (1982) Dose-response analysis of the enhancement of liver tumour formation in CF-1 mice by dieldrin. Carcinogenesis 3: 941–945PubMedCrossRefGoogle Scholar
  19. Thorpe E, Walker AIT (1973) The toxicology of dieldrin (HEOD). 11. Comparative long-term oral toxicity studies in mice with dieldrin, phenobarbitone, β-BHC and y-BHC. Fd Cosmet Toxicol 11: 433–442CrossRefGoogle Scholar
  20. Vesselinovitch SD, Mihailovich N, Rao KVN (1978) Morphology and metastatic nature of induced hepatic nodular lesions in C57BL x C3H F1 mice. Cancer Res 38: 2003–2010PubMedGoogle Scholar
  21. Wachstein M, Meisel E (1957) Histochemistry of hepatic phosphatases at physiological pH. Am J Pathol 27: 13–23Google Scholar
  22. Williams GM (1981) Liver carcinogenesis: the role for some chemicals of an epigenetic mechanism of liver-tumour promotion involving modification of the cell membrane. Fd Cosmet Toxicol 19:577– 583Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • S. D. Gangolli
    • 1
  • B. G. Lake
    • 1
  • J. G. Evans
    • 1
  1. 1.The British Industrial Biological Research AssociationSurreyUK

Personalised recommendations